Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

New genes and pathways are important for testosterone production and male sexual development.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Understanding and tracking our body's natural daily rhythms could help improve heart health.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.